Originally published In Press as doi:10.1074/jbc.M204340200 on May 31, 2002
J. Biol. Chem., Vol. 277, Issue 32, 28934-28941, August 9, 2002
Ancient Ubiquitous Protein 1 Binds to the Conserved
Membrane-proximal Sequence of the Cytoplasmic Tail of the Integrin
Subunits That Plays a Crucial Role in the Inside-out Signaling of
IIb
3*
Atsushi
Kato
§,
Norihiko
Kawamata
,
Kenji
Tamayose
,
Motoki
Egashira
,
Rika
Miura
,
Tsutomu
Fujimura¶,
Kimie
Murayama¶, and
Kazuo
Oshimi
From the
Division of Hematology, Department of
Internal Medicine and ¶ Division of Biochemical
Analysis, Central Laboratory of Medical Sciences, Juntendo University
School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
Received for publication, May 3, 2002, and in revised form, May 29, 2002
 |
ABSTRACT |
Modification of the cytoplasmic tails of the
integrin
IIb
3 plays an important
role in the signal transduction in platelets. We searched for proteins
that bind to the
IIb cytoplasmic tail using the yeast
two-hybrid assay with a cDNA library of the megakaryocyte-derived cell line and identified a protein, ancient ubiquitous protein 1 (Aup1), that is ubiquitously expressed in human cells. Observation of
UT7/TPO cells expressing a red fluorescent protein-tagged Aup1 indicated its localization in the cytoplasm. Immunoprecipitation of
UT7/TPO cells by an antibody for Aup1 revealed that ~40% of
IIb is complexed with Aup1. Binding study with an
IIb cytoplasmic tail peptide and glutathione
S-transferase-Aup1 fusion protein revealed a low affinity
(Kd = 90 µM). Subsequent yeast two-hybrid assay indicated binding of Aup1 to cytoplasmic tails of
other integrin
subunits. Binding study with the purified Aup1 and
various glutathione S-transferase-
IIb
cytoplasmic tail peptides revealed specific binding of Aup1 to the
membrane-proximal sequence (KVGFFKR) that is conserved among the
integrin
subunits and plays a crucial role in the
IIb
3 inside-out signaling. As Aup1
possesses domains related to signal transduction, these results suggest involvement of Aup1 in the integrin signaling.
 |
INTRODUCTION |
Integrin
IIb
3 (GPIIb-IIIa) is one of
the receptors on the cellular surface of platelets and megakaryocytes.
It binds to various adhesive proteins including fibrinogen, von
Willebrand factor, vitronectin, and fibronectin that contain a core
amino acid sequence of arginine-glycine-aspartic acids (RGD). Binding of fibrinogen to
IIb
3 leads to platelet
aggregation and finally to thrombus formation at the injured vascular
sites. A pivotal role of
IIb
3 in
hemostasis is supported by the clinical observation that the congenital
deficiency of
IIb
3, Glanzmann's
thrombasthenia, results in lifelong bleeding tendency (1). Whereas
IIb
3 on resting platelets does not bind
soluble fibrinogen, once platelets are activated, conformation of the
extracellular domains of the
IIb
3 is
altered and its ligand-binding affinity is increased (affinity
modulation) (2). This process of the inside-out signaling is considered
to be mediated by modification of the short cytoplasmic tails of
IIb and
3 subunits; however, the
mechanism remains to be elucidated.
The nuclear magnetic resonance structural analysis of the
IIb cytoplasmic tail revealed a closed conformation
where the highly conserved N-terminal membrane-proximal region forms an
-helix followed by a turn, and the acidic C-terminal loop interacts
with the N-terminal helix (3). Deletion of almost the entire
IIb-cytoplasmic tail and mutations in its N-terminal
sequence (GFFKR) conserved among the integrin
subunits enhance the
affinity of
IIb
3 for ligands (4-6). The
cytoplasmic tail of the
3 subunit also has an amino acid
sequence that is conserved among integrin
subunits: a stretch of 8 amino acids (KLLITIHD) adjacent to the transmembrane domain. In a
similar fashion to the
IIb subunit, deletion or mutation
in this conserved region induces activation of
IIb
3 (6, 7). These observations suggest
that membrane-proximal regions of the cytoplasmic domains of both
subunits exert a negative regulatory function and lock
IIb
3 in a low affinity state. Negative regulation may be mediated by the interaction between
IIb and
3 cytoplasmic tails, possibly
through a salt bridge between Arg-995 in
IIb and Asp-723
in
3 (6), or binding of intracellular proteins to
IIb and/or
3 subunits. Two candidates for
the modulator proteins have been reported: calcium- and
integrin-binding protein (CIB)1 (8) and
3-endonexin (9, 10), which bind to
IIb
and
3 cytoplasmic tails, respectively. Although CIB is
unlikely to have a regulatory effect on
IIb
3 ligand binding function (11),
3-endonexin fused to GST protein induces the
conformational change of
IIb
3 and
activates it when co-transfected with
IIb and
3 subunits in Chinese hamster ovary cells. Another
mechanism of modification has been recently suggested: an interaction
between cytoplasmic tails of
IIb
3 and the
actin cytoskeleton.
IIb
3 and the actin
cytoskeleton are physically linked by binding of talin to the
3 cytoplasmic tail (12), and
IIb
3 in resting platelets may be
constrained in a low affinity state by the actin cytoskeleton (13). An
increase in the cytosolic calcium evoked by agonist stimulation
initiates actin filament turnover and may lead to relief of the
cytoskeletal constraints on
IIb
3,
resulting in a high affinity state of
IIb
3. Among these possible modification mechanisms, which one works in platelets remains to be determined.
In contrast, binding of fibrinogen to
IIb
3 leads to platelet shape change,
release of granules, and platelet aggregation. These sequential
biological phenomena are mediated by the outside-in signaling of
IIb
3, calcium mobilization, increase in
the cytoplasmic pH, thromboxane A2 generation, and tyrosine
phosphorylation of intracellular proteins including focal adhesion
kinase and members of the Src family proteins (1). These signaling
proteins are complexed with the actin cytoskeleton and are recruited to
the focal contacts. In this process, the
3 cytoplasmic
tail (residues 740-762) binds to the adaptor proteins Shc and Grb2
when tyrosine residues (Tyr-747 and Tyr-759) are phosphorylated (14).
In addition, the
3 cytoplasmic tail is involved in clot
retraction by transmitting the contractile force evoked by the
rearrangement of the cytoskeletal proteins to the extracellular matrix
(15). Thus, several proteins that bind to the
3
cytoplasmic tail and are implicated in the
IIb
3 signaling have been identified;
however , little is known about proteins that bind to and modify the
IIb cytoplasmic tail.
In this study, we searched for proteins that bind to the
IIb cytoplasmic tail in the
thrombopoietin-dependent acute megakaryocytic leukemia-derived cell line, UT7/TPO (16), by the yeast-two hybrid assay
and identified a protein, Aup1, that binds to the conserved membrane-proximal sequence of the cytoplasmic tail of the integrin
subunits.
 |
EXPERIMENTAL PROCEDURES |
Cell Lines--
UT7/TPO cell line (16) was maintained with
Iscove's modified Dulbecco's medium supplemented with 20% fetal calf
serum (FCS) and 10 ng/ml recombinant human thrombopoietin (TPO) (Kirin
Brewery, Tokyo, Japan). Cell lines including HL 60, K562, U937, Jurkat, Raji, and CMK (17), established from acute myelocytic leukemia, chronic
myelocytic leukemia, diffuse histiocytic lymphoma, T cell leukemia,
Burkitt (B cell) lymphoma, and acute megakaryocytic leukemia,
respectively, were maintained with RPMI medium supplemented with 10%
FCS. Other cell lines including 293, MCF7, A549, HeLa, and HepG2,
established from embryonic kidney, breast carcinoma, lung
adenocarcinoma, epitheloid cervical carcinoma, and hepatocarcinoma, respectively, were maintained with Dulbecco's modified Eagle's medium
supplemented with 10% FCS.
Amplification of the cDNA Sequence for the Cytoplasmic Domain
of Integrin
and
Subunits by PCR--
The cDNA sequences
for the cytoplasmic domains of various integrin
and
subunits
were amplified by reverse transcription-PCR from RNA extracted from
UT7/TPO for
IIb,
2,
V, and
3, HepG2 for
1, Raji for
5, K562 for
M, and HL60 for
1 and
2, respectively. The cDNA
sequences for a mutant
IIb (F992A) and for
membrane-proximal (
IIb MP; KVGFFKR) and membrane-distal
(
IIb MD; NRPPLEEDDEEGE) segments of the
IIb cytoplasmic tail were amplified using the normal
IIb cytoplasmic tail cDNA. The nucleotide sequence
of each cDNA fragment amplified by PCR was confirmed using the ABI Prism dRhodamine terminator cycle sequencing ready reaction kit (Applied Biosystems Japan, Tokyo, Japan).
Yeast Two-hybrid Assays--
A cDNA library was constructed
by ligating cDNA synthesized from UT7/TPO RNA to a pAD-Gal4 vector
(Stratagene, La Jolla, CA). The cDNA sequence for the cytoplasmic
domain of the integrin
IIb subunit was ligated in-frame
to a pBD-Gal4 vector (Stratagene). Procedures for screening and the
filter lift assay to confirm interactions between the bait and target
proteins were according to the manufacturer's instructions. Briefly,
yeast YRG-2 cells were transformed with a pAD-Gal4 plasmid encoding the
UT7/TPO cDNA and a pBD-Gal4 plasmid encoding the
IIb
bait. Then, yeast cells were plated on selective SD agar plates without
leucine, tryptophan, and histidine (Leu
Trp
His
). Colonies grown on the selective plates, indicating
interactions between target and bait proteins, were subjected to the
filter lift assay to examine the
-galactosidase activity to confirm the interaction. Positive yeast colonies were transferred to Whatman filter papers, frozen in the liquid nitrogen, thawed, and incubated with 5-bromo-4-chloro-3-indolyl-
-D-galactoside (0.3 mg/ml) in Z buffer (per liter, 16.1 g of
Na2HPO4/7H2O, 5.5 g of
NaH2PO4/7H2O, 0.75 g of KCl,
0.246 g of MgSO4/7H2O, and 2.7 ml of
2-mercaptoethanol; pH 7.0). Colonies that produced blue color were
picked up for the subsequent experiments. To examine interactions
between the target protein and cytoplasmic tails of various integrin
subunits including
IIb,
1,
2,
5,
M,
V,
1,
2, and
3, yeast
two-hybrid assays were performed in a similar fashion.
Quantitative
-Galactosidase Assay--
To compare
interactions between the target protein and the cytoplasmic domains of
various integrin subunits, the quantitative
-galactosidase assay
(18) was performed. Briefly, yeast cells grown in 5 ml of medium at
30 °C until the near log phase (OD600 = ~1.0) were
resuspended in Z buffer (200 µl) with glycerol (50 µl). After one
cycle of freeze-thawing, 1 mM PMSF and acid-washed glass
beads were added to the samples, followed by vigorous vortexing. Then,
50 µl of o-nitrophenyl-
-D-galactoside (4 mg/ml, Sigma-Aldrich Japan, Tokyo, Japan) was added to the supernatants
and the samples were incubated at 30 °C until a yellow color
developed. After addition of 120 µl of Na2CO3
(1 M), the OD420 of each sample was measured.
Assays were normalized to the yeast concentration (OD600) of each sample, and the
-galactosidase activity was calculated as
follows;
-galactosidase units = 1,000 × OD420/t × V × OD600, where t = time of incubation in
minutes, V = volume of culture added to Z buffer in ml
(5 ml).
Northern Blot Analysis--
Approximately 30 µg of the total
RNA extracted from UT7/TPO cells was electrophoresed in 1.5%
agarose/formaldehyde gels, transferred to the nylon membranes
(Hybond-N+, Amersham Biosciences, Buckinghamshire, United
Kingdom), and hybridized with a full-length Aup1 cDNA fragment labeled with [
-32P]dCTP using a random-primed DNA
labeling kit (Roche Molecular Biochemicals). To compare the expression
of Aup1 transcripts among different human tissues, the Human 12-lane
MTN Blot (CLONTECH Japan, Tokyo, Japan) was
hybridized with the same probe.
Preparation of the Synthetic Peptides and Antibody
Production--
Peptides for Aup1 (RLTPADKAEHMKRQRHPRLR) (Fig.1,
A and B),
IIb and
3
cytoplasmic tails, to which a cysteine residue was added at the N
terminus for the antibody production, were synthesized using PSSM-8
(Shimadzu, Kyoto, Japan). Each peptide was coupled to the keyhole
limpet hemocyanin (Sigma-Aldrich) and injected subcutaneously to
rabbits for immunization.
Immunoblot Analysis--
Platelets were isolated from the
platelet-rich plasma of the normal peripheral blood, and leukocytes
were isolated from the buffy coat after removal of erythrocytes by
hypotonic lysis in 0.14 M NH4Cl, 20 mM Tris (pH 7.2) at 37 °C. Microscopic observation revealed that more than 90% of the prepared leukocytes were
neutrophils. To extract proteins, platelets, leukocytes, UT7/TPO, and
other cell lines including CMK, HL60, K562, U937, Jurkat, Raji, 293, HepG2, HeLa, MCF7, and A547 were resuspended in the cell lysis buffer
(0.15 M NaCl, 10 mM Tris (pH 7.4), 1 mM PMSF, 1.8 µg/ml aprotinin, 100 µg/ml leupeptin, and
1% Triton X-100). Samples were incubated for 30 min on ice with
occasional vortexing, and the cell lysates were subjected to 10%
SDS-PAGE, transferred to the nitrocellulose membranes (Trans-blot
transfer medium, Nippon Bio-Rad Laboratories, Yokohama, Japan). After
blocking with 5% skimmed milk in Tris-buffered saline buffer (10 mM Tris (pH 7.4), 150 mM NaCl) for 1 h,
membranes were incubated with a preimmune rabbit serum or the rabbit
antiserum for the Aup1 peptide (Aup1-2) for 1 h, and then with
the horseradish peroxidase-conjugated goat anti-rabbit immunoglobulins
(DAKO Japan, Kyoto, Japan). Signals on membranes were
detected with the ECL system (Amersham Biosciences).
Subcellular Localization of Aup1--
To study the subcellular
localization of Aup1, a full-length Aup1 cDNA was ligated into the
pDsRed1-N1 vector that encodes a red fluorescent protein (RFP)
(CLONTECH). Then, UT7/TPO cells were transfected
with a control vector and a plasmid encoding the Aup1-RFP fusion
protein by electroporation using the Gene Pulser II (Bio-Rad). After
selection with neomycin, stable cell lines that express RFP
(UT7/TPO.VR4-4) and Aup1-RFP fusion proteins (UT7/TPO.Aup1 R23-1) were
established. To examine the subcellular localization of Aup1,
UT7/TPO.VR4-4 and UT7/TPO.Aup1R23-1 cells were applied to glass
coverslips and observed using the LSM 510 laser scanning microscope
(Carl Zeiss Microscopy, Jena, Germany) with appropriate filters. For
the nuclear staining, cells were treated with 3.7% formaldehyde in
phosphate-buffered saline and mounted with a medium containing
4',6'-diamidino-2-phenylindole (Vector Laboratories, Burlingame, CA).
Immunoprecipitation--
UT7/TPO cell extracts (600 µg of
protein) with the cell lysis buffer containing 1% digitonin and 1 mM Ca2+ were incubated with a preimmune rabbit
serum or the Aup1-2 antiserum (40 µl) for 1 h, and then with
protein-G-Sepharose beads (30 µl) (Amersham Biosciences) for 3 h
at 4 °C with gentle shaking. After washing with the cell lysis
buffer, the beads were resuspended in the SDS sample buffer and boiled,
and the supernatants were subjected to SDS-PAGE, followed by immunoblot
analysis using mouse monoclonal antibodies for the
IIb
(SZ22, Cosmo Bio, Tokyo, Japan) and
3 subunits (SZ21,
Cosmo Bio). Signals were detected with the ECL system after incubation
with the horseradish peroxidase-conjugated rabbit anti-mouse
immunoglobulins (DAKO). To measure how much part of the cellular
IIb is complexed with Aup1, the immunodepletion assay
was performed. After preincubation with protein-G beads, UT7-TPO cell
lysates (500 µg of protein) were immunoprecipitated twice with the
control rabbit or the Aup1-2 serum (40 µl) and protein-G beads (50 µl). Then, aliquots of the supernatants (1-10 µl) were subjected
to SDS-PAGE, followed by immunoblot analysis using the polyvinylidene
difluoride (PVDF) membrane (Immobilon-P, Millipore, Bedford, MA) and
the SZ22 antibody. Concentration of the residual (free)
IIb subunit was quantified by densitometry of the
respective
IIb bands to calculate the percentage of
IIb bound to Aup1.
GST Pull-down Assay--
The cDNA sequences for Aup1, the
normal and a mutant (F992A)
IIb cytoplasmic tails, and
the membrane-proximal (
IIb MP) and membrane-distal
segments (
IIb MD) were ligated in-frame to the pGEX-4T
vector that encodes GST (Amersham Biosciences). For production of GST
fusion proteins, DH5
cells transfected with the respective plasmids
were incubated at 25 °C until the culture reached the mid-log phase
(OD600 = ~0.8), at which time 25 µM
isopropyl-
-D-thiogalactopyranoside was added. After
incubation for an additional 2 h, the bacteria were resuspended in
phosphate-buffered saline containing 1 mM PMSF and 1 mg/ml
lysozyme, followed by sonication. Triton X-100 was then added (1%),
and the supernatant was incubated with the GSH-Sepharose beads
(Amersham Biosciences) for 30 min at room temperature, followed by
washing with phosphate-buffered saline. To examine association between
Aup1 and cytoplasmic tails of
IIb and
3,
beads that bound the GST-Aup1 fusion protein (125 µg) and the control
GST protein (62.5 µg) were incubated with the UT7/TPO cell extract (1 mg of protein) in the GST reaction buffer (200 µl, the cell lysis
buffer containing 1% Triton X-100) for 3 h at 4 °C with gentle
shaking. Thereafter, beads were washed with the GST reaction buffer,
resuspended in the SDS sample buffer, and boiled, and the supernatant
was subjected to SDS-PAGE, followed by immunoblot analysis using the
PVDF membrane, the rabbit antiserum for the cytoplasmic tails of
IIb and
3, and the horseradish peroxidase-conjugated goat anti-rabbit immunoglobulins. To identify the
IIb sequence to which Aup1 binds, Aup1 cleaved from the
immobilized GST-Aup1 fusion protein by thrombin (Sigma-Aldrich)
according to the manufacturer's instructions was preincubated with
GSH- and GST-Sepharose beads in the GST reaction buffer. Then, the supernatants (50 µl containing 0.7 µg of Aup1; 0.4 µM) was incubated with the immobilized
GST-
IIb cytoplasmic tail fusion proteins (20 µM), including the normal and a mutant (F992A)
IIb,
IIb MP, and
IIb MD
segments, followed by SDS-PAGE and immunoblot analysis using the
PVDF membrane and the Aup1-2 antiserum.
Estimation of the Affinity of Interaction between Aup1 and the
IIb Cytoplasmic Tail--
The synthetic
IIb cytoplasmic peptide was preincubated with the
GST-Sepharose beads for 30 min at room temperature, and the supernatants (20-720 µM) were incubated with the
immobilized GST-Aup1 fusion protein (1 µg, 1.5 µM) for
1 h at room temperature in the GST reaction buffer (10 µl).
Then, various amounts of the supernatants, the original
IIb peptide, and the peptide preabsorbed by GST beads
were subjected to 15% SDS-PAGE, followed by immunoblot analysis using
the PVDF membrane and the rabbit antiserum for the
IIb cytoplasmic tail. The resulting immunoblots of the
IIb
cytoplasmic tail were quantified by densitometry, and the affinity of
Aup1 for binding to the
IIb cytoplasmic tail was
calculated by Scatchard analysis (19).
 |
RESULTS |
Identification of a Protein That Binds to the Integrin
IIb Cytoplasmic Tail--
To search for proteins that
bind to the cytoplasmic tail of the integrin
IIb
subunit, we constructed a cDNA library from a megakaryocyte-derived
cell line, UT7/TPO. UT7/TPO cells constitutively express
IIb
3 on the cellular surface, as
confirmed by fluorescence-activated cell sorting analysis (data not
shown). Screening of the cDNA library by the yeast two-hybrid assay
with a bait of the
IIb cytoplasmic tail identified a
900-bp cDNA fragment that encodes a partial C-terminal peptide
composed of 173 amino acids (48L21) (Fig.
1A). To obtain a cDNA
sequence for the N-terminal portion, we performed PCR using UT7/TPO
cDNA and primers from the 5'-terminal sequence of the cloning site
of pAD-Gal4 (5'-AGGGATGTTTAATACCACTAC-3') and the 5'-terminal sequence
of the 48L21 (5'-GCTGTTGTACACGGAGTGCA-3'). A 400-bp cDNA fragment
(5'-48L21) was amplified, and the nucleotide sequencing revealed the
sequence was continuous to the 5'-terminus of 48L21. For the final
cloning of a full-length cDNA, PCR with UT7/TPO cDNA and
primers from the 5'-terminal sequence of 5'-48L21 (5'-TGCGCCTGGGCGCGAAAATG-3') and 3'-terminal sequence of 48L21 (5'-GGCTCTGGGTGCCATCCTGT-3') was performed. Nucleotide sequencing of
the amplified PCR product (1.3-kb cDNA fragment) revealed that the
protein was composed of 410 amino acids. Subsequent data base searches
indicated that the sequence was identical with the short isoform of
Aup1 (Refs. 20 and 21; GenBankTM accession no. AF100753)
(Fig. 1, A and B).

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 1.
Amino acid sequence and a schematic
representation of Aup1. A, the arrowhead
indicates the position where 66 amino acids are inserted in the
reported long isoform (Ref. 21; GenBankTM accession no.
AF100754). The solid line indicates the amino
acid sequence, against which the rabbit antiserum (Aup1-2) was raised.
The broken line indicates the sequence encoded by
48L21 that was identified by the yeast two-hybrid assay. B,
the shaded area and the arrowhead
represent a putative signal sequence and a signal cleavage site,
respectively. Aup1-2, the peptide used for antibody
production; PlsC, phosphate acyltransferase domain;
CUE, coupling of ubiquitin conjugation to the endoplasmic
reticulum degradation domain.
|
|
Aup1 Is Ubiquitously Expressed in Human Cells and
Tissues--
Northern blot analysis with the total RNA extracted from
UT7/TPO cells using a full-length Aup1 cDNA probe revealed a
transcript of ~1.7 kb (Fig.
2A). Because it was reported
that Aup1 is expressed in all mouse tissues (20), we examined the
expression of Aup1 transcripts in various human tissues. In concordance
with the mouse tissues, Aup1 was expressed in all human tissues
examined (Fig. 2B). To examine the expression of the Aup1
protein in UT7-TPO cells, platelets, leukocytes, and other cell lines,
a rabbit antiserum was raised against a synthetic peptide for Aup1
(Fig. 1, A and B). Immunoblot analysis using this
antiserum (Aup1-2) revealed duplicate bands of ~40 kDa at the
reducing as well as non-reducing conditions in UT7/TPO cells (Fig.
3A). These bands were observed in other cell lines including CMK, HL60, K562, U937, Jurkat, Raji, HepG2, 293, HeLa, MCF7, and A547 (Fig. 3B). Treatment with
the protein phosphatases did not change intensity of these two bands (data not shown). In contrast, only a smaller band was detected in
platelets and leukocytes (Fig. 3C).

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 2.
Expression of the Aup1 transcripts in human
cells and tissues. A, total RNA of UT7/TPO cells was
probed with a 32P-labeled Aup1 cDNA fragment.
B, mRNA on the Human 12-lane MTN Blot
(CLONTECH) was hybridized with the same probe;
leukocytes (lane 1), lung (lane
2), placenta (lane 3), small intestine
(lane 4), liver (lane 5),
kidney (lane 6), spleen (lane
7), thymus (lane 8), colon
(lane 9), skeletal muscle (lane
10), heart (lane 11), and brain
(lane 12). Arrows indicate an Aup1
transcript (~1.7 kb), and the arrowhead (~2.1 kb) (B)
may represent an alternatively spliced transcript. Molecular size
markers are presented (28 and 18 S; ribosomal RNA, 2.4 and 1.35 (RNA
size markers in kb)). 2MG, filters were
reprobed with a 32P-labeled 2-microglobulin
cDNA.
|
|

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 3.
Expression of Aup1 protein in human
cells. A, protein (150 µg) extracted from UT7/TPO
cells were probed with a preimmune rabbit serum (lane
1), a rabbit antiserum for Aup1 (Aup1-2) (lane
2), and Aup1-2 with a synthetic Aup1 peptide (80 nM) (lane 3). Duplicate bands
disappeared when an Aup1 peptide was added to the Aup1-2 antiserum,
indicating that Aup1-2 recognizes the peptide sequence
(lane 3). Protein size markers (kDa) are
presented. B, protein extracts (150 µg) from human cell
lines including 293 (lane 1), MCF7
(lane 2), A549 (lane 3),
HeLa (lane 4), HepG2 (lane
5), Jurkat (lane 6), Raji
(lane 7), U937 (lane 8),
K562 (lane 9), HL 60 (lane
10), CMK (lane 11), and UT7/TPO
(lane 12) were probed with Aup1-2. -actin;
filters were reprobed with an anti- actin antibody (Sigma).
C, protein extracts from UT7/TPO cells (150 µg,
lanes 1 and 2), platelets (100 µg,
lanes 3 and 4), and leukocytes (125 µg, lanes 5 and 6) were probed with
a preimmune rabbit serum (lanes 1, 3,
and 5) and Aup1-2 (lanes 2,
4, and 6). Arrowheads indicate Aup1.
Although duplicate bands of ~40 kDa were observed in cell lines, only
a smaller band was detected in platelets and leukocytes.
|
|
Aup1 Is Present in Cytoplasm--
To examine the subcellular
localization of Aup1, stable UT7/TPO cell lines that express the
Aup1-RFP fusion protein (UT7/TPO.Aup1R23-1) and the control RFP
(UT7/TPO.VR4-4) were established.
Overexpression of Aup1 did not affect the expression of
IIb
3 on the cellular surface, as
confirmed by fluorescence-activated cell sorting analysis of
UT7/TPO, UT7/TPO.VR4-4, and UT7/TPO.Aup1R23-1 cells (data not shown). Observation of UT7/TPO.VR4-4 and UT7/TPO.Aup1 R23-1 cells by confocal microscopy revealed that RFP was distributed evenly throughout the cell; however, the Aup1-RFP fusion protein was observed
in the cytoplasm, but not in the nucleus
(Fig. 4). Because it was reported that the N terminus of mouse Aup1
resembles the signal peptide of secreted protein, followed by a
putative signal cleavage site, we examined whether Aup1 is secreted
from cells. Immunoblot analysis with the culture supernatant of UT7/TPO
cells using the Aup1-2 antiserum revealed that Aup1 could not be
detected in the concentrated (10-fold) culture supernatant (data not
shown). These results indicate that Aup1 is a cytoplasmic protein.

View larger version (53K):
[in this window]
[in a new window]
|
Fig. 4.
Subcellular localization of Aup1.
Confocal microscopy of the stable UT7/TPO cell lines expressing an RFP
(UT7/TPO.VR4-4) (a and c) and an Aup1-RFP
fusion protein (UT7/TPO.Aup1R23-1) (b and d).
Nucleus was stained by 4',6'-diamidino-2-phenylindole (c and
d). Although RFP is distributed evenly throughout the cell
(a and c), the Aup1-RFP fusion protein was
observed in the cytoplasm without localization in the nucleus
(b and d). White bars represent 10 µm.
|
|
Approximately 40% of the
IIb Subunit Is Complexed
with Aup1 in UT7/TPO Cells--
To examine whether Aup1 is associated
with the
IIb cytoplasmic tail in the eukaryotic cells,
UT7-TPO cell lysate was immunoprecipitated with the Aup1-2 antiserum.
Immunoblot analysis with the precipitates using anti-
IIb
and -
3 antibodies indicated that Aup1 bound to the
IIb, but not to the
3 subunit (Fig.
5A). We then measured how much
of the cellular
IIb subunit is complexed with Aup1 by the immunodepletion assay. Densitometric analysis of the resulting
IIb bands with the supernatants of the UT7-TPO cell
lysate after immunoprecipitation with the Aup1-2 and the control
rabbit serum revealed that 41.7 ± 3.2% (mean ± S.D.,
results from three independent experiments) of the
IIb
subunit was complexed with Aup1 (data not shown). Binding of Aup1 to
the
IIb cytoplasmic tail was confirmed by the GST
pull-down assay, revealing that GST-tagged Aup1 binds to the
IIb, but not to the
3 subunit (Fig.
5B).

View larger version (58K):
[in this window]
[in a new window]
|
Fig. 5.
Interaction between Aup1 and the cytoplasmic
tail of the integrin IIb
subunit. A, immunoprecipitation. UT7/TPO cell lysate
(600 µg of protein) coprecipitated with a preimmune rabbit serum
(lanes 1-3) and an antiserum for Aup1 (Aup1-2)
(lanes 4-6), and the control lysate (30 µg,
lanes 7-9) were probed with the control mouse
immunoglobulin (lanes 1, 4, and
7), the mouse monoclonal antibodies for IIb
(SZ22) (lanes 2, 5, and 8)
and 3 (SZ21) subunits (lanes 3,
6, and 9). Arrowheads indicate the
IIb subunit. Filters (lanes 4-6)
were reprobed with the antiserum for Aup1 (Aup1-2) (strips
below lanes 4-6). B, GST
pull-down assay. Control GST protein (lanes 1-3)
and the GST-Aup1 fusion protein (lanes 4-7) that
bound to GSH-Sepharose beads were incubated with UT7/TPO cell lysates.
These samples (lanes 1-7) and the UT7/TPO cell
lysate (100 µg of protein, lanes 8-10) were
probed with a preimmune rabbit serum (lanes 1,
4, and 8), rabbit antiserum against
IIb (lanes 2, 5, and
9) and 3 cytoplasmic tails (lanes
3, 7, and 10). To examine competition,
the IIb cytoplasmic tail peptide (0.8 µM)
was added to the antiserum against the same peptide (lane
6). Arrowheads indicate IIb
subunits. Strips were reprobed with the goat antiserum for GST
(Amersham Biosciences); GST (strips below
lanes 1-3) and GST-Aup1 fusion protein
(strips below lanes
4-7).
|
|
Aup1 Interacts with the
IIb Cytoplasmic Tail with a
Low Affinity--
We next studied interaction between the synthetic
peptide for the
IIb cytoplasmic tail and immobilized
GST-Aup1 fusion protein to measure the affinity of interaction. The
Kd value calculated from the Scatchard plot analysis
was 90 µM, suggesting a relatively weak affinity of
interaction between Aup1 and the
IIb cytoplasmic tail
(Fig. 6).

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 6.
Estimation of the affinity of interaction
between Aup1 and the IIb
cytoplasmic tail. A, various amounts of the synthetic
peptide for the IIb cytoplasmic tail were incubated with
the immobilized GST-Aup1 fusion protein, followed by SDS-PAGE and
immunoblot analysis with the antiserum for the IIb
cytoplasmic tail. The amounts of the IIb peptide bound
to Aup1 were quantified by densitometry. B, Scatchard plot
of the same data was linear, giving Kd value of 90 µM.
|
|
Aup1 Binds to Cytoplasmic Tails of Various Integrin
Subunits--
As Aup1 is expressed ubiquitously in human cells and
tissues, we examined whether Aup1 binds to cytoplasmic tails of other integrin
as well as
subunits by the yeast two-hybrid assays. Yeast cells were co-transformed with plasmids encoding Aup1 (48L21) and
cytoplasmic tails of
IIb,
1,
2,
5,
V,
M,
1,
2, and
3. In selective
Leu
Trp
His
plates, only
colonies co-transformed with Aup1 and
subunits grew. These colonies
were positive for both of the filter lift assay and the quantitative
-galactosidase assay (Fig. 7). These results indicate that Aup1 binds to cytoplasmic tails of various integrin
subunits.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 7.
Quantitative
-galactosidase assay indicating associations
between Aup1 and cytoplasmic tails of the integrin subunits. Interactions between Aup1 and cytoplasmic tails of
various integrin and subunits in the yeast two-hybrid assay are
presented as activity of -galactosidase. Yeast cells transfected
with Aup1 (Aup1), Aup1 with the control pBD-Gal4 vector (pBD), Aup1
with subunits ( IIb, 1,
2, 5, V, and
M), and Aup1 with subunits ( 1,
2, and 3), were grown in
Leu , Leu Trp ,
Leu Trp His , and
Leu Trp selective medium, respectively.
Bars represent the mean ± S.D. of three separate
experiments, each performed on five independent colonies.
|
|
Aup1 Binds to the Conserved Membrane-proximal Sequence of the
Cytoplasmic Tail of the Integrin
Subunits--
The amino acid
sequence of the membrane-proximal region of the cytoplasmic tail is
highly conserved among the integrin
subunits and plays a crucial
role in the inside-out signaling of
IIb
3 (4-6). As the results from the yeast two-hybrid assay suggested binding of Aup1 to this conserved sequence, we examined interaction between the purified Aup1 and immobilized GST fusion proteins of the
IIb cytoplasmic tail, including the normal and a mutant (F992A)
IIb that leads to the high affinity state of
IIb
3 (6), and the membrane-proximal
(KVGFFKR) and membrane-distal (NRPPLEEDDEEGE) sequences. The GST
pull-down assay revealed binding of Aup1 to the normal and the
membrane-proximal
IIb sequence, but neither to the
mutant nor to the membrane-distal sequence (Fig.
8). These results indicate that Aup1
binds to the specific short amino acid stretch that is located at the
membrane-proximal region and conserved among the cytoplasmic tails of
the integrin
subunits.

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 8.
Interaction between Aup1 and
GST- IIb cytoplasmic tail fusion
proteins. 50 ng of the purified Aup1 (lane
1) and 0.7 µg (0.4 µM) incubated with the
immobilized GST fusion proteins (20 µM) of the
IIb cytoplasmic tail, including the normal
IIb (lane 2), membrane-proximal
sequence (KVGFFKR) (lane 3), membrane-distal
sequence (NRPPLEEDDEEGE) (lane 4), and a mutant
IIb (F992A) (lane 5), were
subjected to immunoblot analysis using antiserum for Aup1 (Aup1-2).
Arrowheads represent Aup1 and thick
bands at the bottom of lanes
2-5 represent respective GST- IIb cytoplasmic
peptide fusion proteins.
|
|
 |
DISCUSSION |
One of the obstacles to elucidate the integrin
IIb
3 signaling is the absence of
appropriate cell lines that exhibit similar properties to platelets
including expression of
IIb
3 and
intracellular signaling molecules, and the response to platelet
physiological agonists. Because the
IIb subunit is
exclusively expressed in platelets and megakaryocytes, it is suggested
that a megakaryocyte-derived cell line would be suitable to search for
proteins that bind to the
IIb cytoplasmic tail. In this
study, we performed the yeast two-hybrid assay and screened the
cDNA library from UT7/TPO cells using the
IIb
cytoplasmic tail as bait. Binding of Aup1 to the
IIb
cytoplasmic tail was demonstrated by the following results. First, Aup1
bound to the
IIb cytoplasmic tail in the yeast
two-hybrid assay. Second, Aup1 is a cytoplasmic protein, as indicated
by the observation with the confocal microscopy of UT7/TPO cells that
express an RFP-tagged Aup1. Third, the
IIb subunit was
present in the immunoprecipitate of the UT7-TPO cell lysate by the
antiserum for Aup1. Fourth, GST-tagged Aup1 bound to the
IIb subunit in the UT7-TPO cells.
The N terminus of Aup1 is hydrophobic and resembles the signal sequence
of secreted proteins, followed by an 11-amino acid sequence with
similarity to a prokaryotic lipid attachment site (20) (Fig.
1B). These characteristic amino acid sequences and the
present observations with confocal microscopy and immunoblot analysis
with the culture supernatant of UT7/TPO cells suggest that Aup1 is a
cytoplasmic protein in possible association with the plasma membrane.
Immunoblot analysis with the antiserum for an Aup1 peptide revealed
duplicate bands of ~40 kDa with an estimated molecular mass
difference of ~3-4 kDa in UT7/TPO and other cell lines. In contrast,
only a smaller band was detected in platelets and leukocytes. Although
only a single cDNA fragment encoding 410 amino acids was amplified
by PCR with UT7/TPO cDNA in the present study, a long isoform of
Aup1 composed of 476 amino acids has been reported to be produced by
alternative splicing of the Aup1 gene (21). However, considering the
difference in the number of amino acids (66) between these two
isoforms, it is unlikely that duplicate bands observed in the
immunoblot analysis are produced by alternative splicing. Another
possible examination is the posttranslational modification including
glycosylation, phosphorylation, and cleavage. As the consensus amino
acid sequences for the O- and N-linked glycosylation sites are absent in Aup1 and only a smaller band is
observed in terminally differentiated platelets and leukocytes, it is
hard to explain that the larger protein represents a glycosylated mature protein. With regard to phosphorylation, tyrosine, serine, and/or threonine residues are phosphorylated upon cellular stimulation as observed in a number of intracellular signaling proteins.
However, modification by phosphorylation is unlikely because duplicate bands were constitutively expressed and did not exhibit any difference in their intensity after treatment with the protein phosphatase in the
immunoblot analysis. On the other hand, the difference in the estimated
molecular mass of these two bands (~3-4 kDa) is concordant with that
of the postulated signal sequence composed of 37 amino acids.
Accordingly, it is conceivable that a larger band represents a
precursor protein subjected to cleavage to the smaller mature protein,
followed by possible modification with lipid attachment including
myristoylation, prenylation, and/or palmitoylation to be associated
with the internal leaflet of the plasma membrane (22).
It was reported that mouse Aup1 also consists of 410 amino acids and is
expressed in all mouse tissues. In addition, it exhibits an amino acid
sequence similar to those of Caenorhabditis
elegans and human Aup1 (20). Because of its evolutionary
conservation of the amino acid sequence and ubiquitous expression, it
appears that Aup1 plays an essential role in cell biology. It was
unexpected that Aup1, a ubiquitously expressed protein in various
tissues, binds to the cytoplasmic tail of the
IIb
subunit that is exclusively expressed in platelets and megakaryocytes.
Accordingly, we examined whether Aup1 binds to the cytoplasmic tails of
other integrin
as well as
subunits. The yeast two-hybrid assays
revealed that Aup1 binds to the cytoplasmic tails of the
1,
2,
5,
M, and
V subunits, but not to the
1,
2, and
3 subunits, indicating specific
binding of Aup1 to the integrin
subunits. To confirm association
between Aup1 and these
subunits, we performed immunoprecipitation using cell lines that express a relatively high level of these
subunits, including IMR32 treated by retinoic acid for
1, CCRF-CEM for
2, HeLa treated by IL-6
for
5, K562 for
M, and RAW264.7 for
V. However, we could co-precipitate Aup1 with these
integrin
subunits neither by the Aup1-2 nor by various antiserum
for these subunits, probably because the expression level of these proteins is extremely low compared with the
IIb subunit
in UT7/TPO cells (data not shown). On the other hand, subsequent GST
pull-down assay indicated binding of Aup1 to the membrane-proximal
amino acid sequence (KVGFFKR) that is conserved among the cytoplasmic tails of the integrin
subunits. Accordingly, it seems that one of
the essential biological functions of Aup1 is to bind to the cytoplasmic tail of the integrin
subunits through the conserved membrane-proximal sequence.
A data base search for the homologous domain structure
revealed that Aup1 possesses two domains: CUE and PlsC domains (23). The yeast protein Cue1p is a prototype of CUE domain family and belongs
to the integral endoplasmic reticulum membrane proteins. It exhibits a
scaffolding activity and recruits the ubiquitin-conjugating enzymes
Ubc7p and Ubc6p in the proximity of the translocon pore cytoplasmic
exit to deliver proteins for ubiquitination and subsequent digestion by
the proteasome (24). The CUE domain is also present in several
eukaryotic cytoplasmic proteins. It was suggested that some of the
CUE-containing proteins are not associated with endoplasmic reticulum
and possess functions different from that of Cue1p (23). Recent studies
identified two eukaryote proteins with the CUE domain, Toll-interacting
protein (Tollip) and transforming growth factor
-activated kinase1
(TAK1)-binding protein 2 (TAB2), that exhibit novel functions in the
IL-1 signal transduction pathway. Tollip is present in a complex with
the serine/threonine IL-1 receptor (IL-1R)-associated kinase (IRAK) and
binding of IL-1 to IL-1R results in the rapid assembly of a
membrane-proximal signaling complex that consists of IL-1R, an adaptor
protein (myeloid differentiation protein; MyD88), IRAK, and Tollip.
Because overexpression of Tollip results in impaired IL-1
-induced
activation of the nuclear transcription factor
B and c-Jun
N-terminal kinase, it may inhibit IL-1 signaling by silencing
components of the signaling cascade including IRAK (25). TAB2 is an
adaptor protein that mediates activation of TAK1. IL-1 stimulates
translocation of TAB2 from the membrane to the cytosol where it
mediates association of TAK1 with the tumor necrosis factor
receptor-associated factor 6 (TRAF6), leading to activation of TAK1
(26).
In addition to possessing the CUE domain, the amino acid sequence of
Aup1 exhibits a significant similarity to taffazins that belong to the
acyltransferase superfamily (27, 28), suggesting that Aup1 may exhibit
an enzymatic activity. Taffazins are composed of a highly hydrophobic N
terminus of 30 amino acids that may serve a membrane anchor and a
central hydrophilic domain composed of 72 residues that may serve as an
exposed loop interacting with other proteins. Mutations of a gene
encoding taffazins (G4.5) lead to a severe inherited (X-linked)
disorder, Barth syndrome, that is characterized by cardiac and skeletal
myopathy, short stature, and neutropenia, indicating an essential
biological function of taffazins (29). Acyltransferases of the tafazzin
superfamily all function in phospholipid synthesis and have either
glycerophosphate (GPAT, EC 2.3.15), 1-acylglycerophosphate (AGPAT,
EC2.3.1.51), 2-acylglycerophosphate, or
2-acylglycerophosphoethanolamine acyltransferase activity (28). The
initial step of phospholipid biosynthesis involves the acylation of
glycerol-3-phosphate by GPAT to form lysophosphatidic acid (LPA),
followed by acylation of LPA by AGPAT to form phosphatidic acid (PA).
In addition to being the key intermediates in the phospholipid
biosynthesis, PA and LPA are the essential lipid messengers in signal
transduction. Thrombin stimulation leads to production of LPA, followed
by its extracellular release in platelets. Binding of LPA to its G
protein-coupled receptor leads to stimulation of phospholipases C and
D, inhibition of adenylyl cyclase, activation of Ras and the downstream
Raf/mitogen-activated protein kinase pathway, and tyrosine
phosphorylation of focal adhesion proteins accompanied by remodeling of
the actin cytoskeleton in the integrin signaling pathway (30). In
contrast, PA can act as an intracellular as well as an extracellular
messenger, activating phospholipase C and the numerous protein kinases
involved in the signal transduction of the protein kinase C and
Raf/mitogen-activated protein kinase pathways (31, 32). Moreover,
fibrinogen binding to
IIb
3 incorporated
into PA-containing lipid vesicles is enhanced, indicating that PA can
modulate affinity of
IIb
3 within a
membrane environment (33). Implications in signal transduction have
also been reported both with GPAT and AGPAT; insulin and epidermal growth factor activate GPAT and increase de novo PA
synthesis, which may amplify diacylglycerol-protein kinase C signaling
(34). Stimulation with IL-1
increases AGPAT activity and leads to an enhanced transcription and synthesis of tumor necrosis factor-
and
IL-6, suggesting AGPAT may amplify cellular signaling responses from
cytokines (32).
Taken together, it is conceivable that Aup1 is involved in the integrin
signaling. Binding of Aup1 to the cytoplasmic tail of the integrin
subunits may alter interactions between
and
cytoplasmic tails,
including interference of the salt bridge formation as predicted
between Arg-995 in
IIb and Asp-723 in
3.
Otherwise, Aup1 may function as an adaptor protein by its CUE domain
and recruit signaling molecules to integrin cytoplasmic tails, or exert
a phosphate acyltransferase activity by its PlsC domain, leading to
alternation in the local concentrations of PA and LPA. Consequently,
conformation of the integrin extracellular domains may be altered
(inside-out signaling), or the sequential biological phenomenon evoked
by ligand binding may be modulated (outside-in signaling). The GST
pull-down assay indicated binding of Aup1 to the conserved
membrane-proximal sequence of the integrin
subunits. As deletions
or mutations in this region lead to an increase in the affinity of
IIb
3 for ligands (4-6) and a mutation in
this region (F992A) prevents binding of Aup1, it is conceivable that
binding of Aup1 to this sequence may sustain integrin in a low affinity
state. In the inside-out signaling of platelets, thrombin stimulation
leads to the rapid activation of tyrosine kinases, including Syk, which
is activated within seconds (35), and Src family kinases, and tyrosine
phosphorylation of the signaling proteins (36). Considering the
remarkable rapidity of this signaling process, Aup1 which binds to the
IIb cytoplasmic tail reversibly as suggested by the
relatively low affinity of interaction, may be suitable for one of the
modulators in the
IIb
3 inside-out signaling. However, further studies are necessary to elucidate implication of Aup1 in the integrin signaling and other biological functions.
 |
ACKNOWLEDGEMENT |
We are grateful to Dr. N. Komatsu for
providing UT7/TPO cells.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed. Tel.: 81-3-3813-3111;
Fax: 81-3-3813-0841; E-mail:
atkato@med.juntendo.ac.jp.
Published, JBC Papers in Press, May 31, 2002, DOI 10.1074/jbc.M204340200
 |
ABBREVIATIONS |
The abbreviations used are:
CIB, calcium- and
integrin-binding protein;
Aup1, ancient ubiquitous protein 1;
GST, glutathione S-transferase;
CUE, coupling of ubiquitin
conjugation to the endoplasmic reticulum degradation;
PlsC, phosphate
acyltransferase;
TPO, thrombopoietin;
RFP, red fluorescent protein;
Tollip, Toll-interacting protein;
TAK1, transforming growth factor
-activated kinase 1;
TAB2, transforming growth factor
-activated
kinase 1-binding protein 2;
IL, interleukin;
IL-1R, interleukin-1
receptor;
IRAK, interleukin-1 receptor-associated kinase;
GPAT, glycerophosphate acyltransferase;
AGPAT, 1-acylglycerophosphate
acyltransferase;
LPA, lysophosphatidic acid;
PA, phosphatidic acid;
FCS, fetal calf serum;
PMSF, phenylmethylsulfonyl fluoride;
PVDF, polyvinylidene difluoride;
MD, membrane-distal;
MP, membrane-proximal.
 |
REFERENCES |
| 1.
|
Kato, A.
(1997)
Crit. Rev. Oncol./Hematol.
26,
1-23[Medline]
[Order article via Infotrieve]
|
| 2.
|
Smyth, S. S.,
Joneckis, C. C.,
and Parise, L. V.
(1993)
Blood
81,
2827-2843[Free Full Text]
|
| 3.
|
Vinogradova, O.,
Haas, T.,
Plow, E. F.,
and Qin, J.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
1450-1455[Abstract/Free Full Text]
|
| 4.
|
O'Toole, T. E.,
Mandelman, D.,
Forsyth, J.,
Shattil, S. J.,
Plow, E. F.,
and Ginsberg, M. H.
(1991)
Science
254,
845-847[Abstract/Free Full Text]
|
| 5.
|
O'Toole, T. E.,
Katagiri, Y.,
Faull, R. J.,
Peter, K.,
Tamura, R.,
Quaranta, V.,
Loftus, J. C.,
Shattil, S. J.,
and Ginsberg, M. H.
(1994)
J. Cell Biol.
124,
1047-1059[Abstract/Free Full Text]
|
| 6.
|
Hughes, P. E.,
Diaz-Gonzalez, F.,
Leong, L., Wu, C.,
McDonald, J. A.,
Shattil, S. J.,
and Ginsberg, M. H.
(1996)
J. Biol. Chem.
271,
6571-6574[Abstract/Free Full Text]
|
| 7.
|
Hughes, P. E.,
O'Toole, T. E.,
Ylanne, J.,
Shattil, S. J.,
and Ginsberg, M. H.
(1995)
J. Biol. Chem.
270,
12411-12417[Abstract/Free Full Text]
|
| 8.
|
Naik, U. P.,
Patel, P. M.,
and Paraise, L. V.
(1997)
J. Biol. Chem.
272,
4651-4654[Abstract/Free Full Text]
|
| 9.
|
Shattil, S. J.,
O'Toole, T.,
Eigenthaler, M.,
Thon, V.,
Williams, M.,
Babior, B. M.,
and Ginsberg, M. H.
(1995)
J. Cell Biol.
131,
807-816[Abstract/Free Full Text]
|
| 10.
|
Kashiwagi, H.,
Schwartz, M. A.,
Eigenthaler, M.,
Davis, K. A.,
Ginsberg, M. H.,
and Shattil, S. J.
(1997)
J. Cell Biol.
137,
1433-1443[Abstract/Free Full Text]
|
| 11.
|
Vallar, L.,
Melchior, C.,
Plançon, S.,
Drobecq, H.,
Lippens, G.,
Regnault, V.,
and Kieffer, N.
(1999)
J. Biol. Chem.
274,
17257-17266[Abstract/Free Full Text]
|
| 12.
|
Calderwood, D. A.,
Zent, R.,
Grant, R.,
Rees, D. J.,
Hynes, R. O.,
and Ginsberg, M. H.
(1999)
J. Biol. Chem.
274,
28071-28077[Abstract/Free Full Text]
|
| 13.
|
Bennett, J. S.,
Zigmond, S.,
Vilaire, G.,
Cunningham, M. E.,
and Bednar, B.
(1999)
J. Biol. Chem.
274,
25301-25307[Abstract/Free Full Text]
|
| 14.
|
Law, D. A.,
Nannizzi-Alaimo, L.,
and Phillips, D. R.
(1996)
J. Biol. Chem.
271,
10811-10815[Abstract/Free Full Text]
|
| 15.
|
Chen, Y.-P.,
O'Toole, T. E.,
Leong, L.,
Liu, B.-Q.,
Diaz-Gonzalez, F.,
and Ginsberg, M. H.
(1995)
Blood
86,
2606-2615[Abstract/Free Full Text]
|
| 16.
|
Komatsu, N.,
Kunitama, M.,
Hagiwara, T.,
Kato, T.,
Miyazaki, H.,
Eguchi, M.,
Yamamoto, M.,
and Miura, Y.
(1996)
Blood
87,
4552-4560[Abstract/Free Full Text]
|
| 17.
|
Sato, T.,
Fuse, A.,
Eguchi, M.,
Hayashi, Y.,
Ryo, R.,
Adachi, M.,
Kishimoto, Y.,
Teramura, M.,
Mizoguchi, H.,
Shima, Y.,
Komori, I.,
Sunami, S.,
Okimoto, Y.,
a |